Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients with pre-capillary pulmonary hypertension of unknown origin. There is considerable variability in the clinical presentation of these patients. Using data from the Comparative, Prospective Registry of Newly Init...
Gespeichert in:
Veröffentlicht in: | The Journal of heart and lung transplantation 2020-12, Vol.39 (12), p.1435-1444 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1444 |
---|---|
container_issue | 12 |
container_start_page | 1435 |
container_title | The Journal of heart and lung transplantation |
container_volume | 39 |
creator | Hoeper, Marius M. Pausch, Christine Grünig, Ekkehard Klose, Hans Staehler, Gerd Huscher, Doerte Pittrow, David Olsson, Karen M. Vizza, Carmine Dario Gall, Henning Benjamin, Nicola Distler, Oliver Opitz, Christian Gibbs, J. Simon R. Delcroix, Marion Ghofrani, H. Ardeschir Rosenkranz, Stephan Ewert, Ralf Kaemmerer, Harald Lange, Tobias J. Kabitz, Hans-Joachim Skowasch, Dirk Skride, Andris Jureviciene, Elena Paleviciute, Egle Miliauskas, Skaidrius Claussen, Martin Behr, Juergen Milger, Katrin Halank, Michael Wilkens, Heinrike Wirtz, Hubert Pfeuffer-Jovic, Elena Harbaum, Lars Scholtz, Werner Dumitrescu, Daniel Bruch, Leonhard Coghlan, Gerry Neurohr, Claus Tsangaris, Iraklis Gorenflo, Matthias Scelsi, Laura Vonk-Noordegraaf, Anton Ulrich, Silvia Held, Matthias |
description | The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients with pre-capillary pulmonary hypertension of unknown origin. There is considerable variability in the clinical presentation of these patients.
Using data from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension, we performed a cluster analysis of 841 patients with IPAH based on age, sex, diffusion capacity of the lung for carbon monoxide (DLCO; |
doi_str_mv | 10.1016/j.healun.2020.09.011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2452977933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053249820317587</els_id><sourcerecordid>2452977933</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-434c121e5cbabae9061138eda8829869f2df07aef34f661551285c81f4bef9b03</originalsourceid><addsrcrecordid>eNp9kMtO3TAQQK2qqFDgDxDyspukfuXhDRK6ghYJRFW1a8txxsRXiR3sBCl_j9GFLruah87MaA5CF5SUlND6-74cQI-rLxlhpCSyJJR-Qie0qpqCU9p8zjmpeMGEbI_R15T2hBDGK_YFHXNOWkYaeYL8Xe_CrJfBGTyv4xS8jhvWcYHo9IiHbYac--SCx_MAPiy5k3APGZichx53GzbjmnKNtdfjllzCNoYJLwPg3ePDr5vf1zjCk0tL3M7QkdVjgvP3eIr-3t782f0s7h9_3O2u7wsjGrEUggtDGYXKdLrTIElNKW-h123LZFtLy3pLGg2WC1vX-WXK2sq01IoOrOwIP0XfDnvnGJ5XSIuaXDIwjtpDWJNiomKyaSTnGRUH1MSQUgSr5uimbEFRot5Mq706mFZvphWRKpvOY5fvF9Zugv7f0IfaDFwdAMh_vjiIKhkH3kDvIphF9cH9_8Ir1M2TTg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452977933</pqid></control><display><type>article</type><title>Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry</title><source>Elsevier ScienceDirect Journals</source><creator>Hoeper, Marius M. ; Pausch, Christine ; Grünig, Ekkehard ; Klose, Hans ; Staehler, Gerd ; Huscher, Doerte ; Pittrow, David ; Olsson, Karen M. ; Vizza, Carmine Dario ; Gall, Henning ; Benjamin, Nicola ; Distler, Oliver ; Opitz, Christian ; Gibbs, J. Simon R. ; Delcroix, Marion ; Ghofrani, H. Ardeschir ; Rosenkranz, Stephan ; Ewert, Ralf ; Kaemmerer, Harald ; Lange, Tobias J. ; Kabitz, Hans-Joachim ; Skowasch, Dirk ; Skride, Andris ; Jureviciene, Elena ; Paleviciute, Egle ; Miliauskas, Skaidrius ; Claussen, Martin ; Behr, Juergen ; Milger, Katrin ; Halank, Michael ; Wilkens, Heinrike ; Wirtz, Hubert ; Pfeuffer-Jovic, Elena ; Harbaum, Lars ; Scholtz, Werner ; Dumitrescu, Daniel ; Bruch, Leonhard ; Coghlan, Gerry ; Neurohr, Claus ; Tsangaris, Iraklis ; Gorenflo, Matthias ; Scelsi, Laura ; Vonk-Noordegraaf, Anton ; Ulrich, Silvia ; Held, Matthias</creator><creatorcontrib>Hoeper, Marius M. ; Pausch, Christine ; Grünig, Ekkehard ; Klose, Hans ; Staehler, Gerd ; Huscher, Doerte ; Pittrow, David ; Olsson, Karen M. ; Vizza, Carmine Dario ; Gall, Henning ; Benjamin, Nicola ; Distler, Oliver ; Opitz, Christian ; Gibbs, J. Simon R. ; Delcroix, Marion ; Ghofrani, H. Ardeschir ; Rosenkranz, Stephan ; Ewert, Ralf ; Kaemmerer, Harald ; Lange, Tobias J. ; Kabitz, Hans-Joachim ; Skowasch, Dirk ; Skride, Andris ; Jureviciene, Elena ; Paleviciute, Egle ; Miliauskas, Skaidrius ; Claussen, Martin ; Behr, Juergen ; Milger, Katrin ; Halank, Michael ; Wilkens, Heinrike ; Wirtz, Hubert ; Pfeuffer-Jovic, Elena ; Harbaum, Lars ; Scholtz, Werner ; Dumitrescu, Daniel ; Bruch, Leonhard ; Coghlan, Gerry ; Neurohr, Claus ; Tsangaris, Iraklis ; Gorenflo, Matthias ; Scelsi, Laura ; Vonk-Noordegraaf, Anton ; Ulrich, Silvia ; Held, Matthias</creatorcontrib><description>The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients with pre-capillary pulmonary hypertension of unknown origin. There is considerable variability in the clinical presentation of these patients.
Using data from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension, we performed a cluster analysis of 841 patients with IPAH based on age, sex, diffusion capacity of the lung for carbon monoxide (DLCO; <45% vs ≥45% predicted), smoking status, and presence of comorbidities (obesity, hypertension, coronary heart disease, and diabetes mellitus). A hierarchical agglomerative clustering algorithm was performed using Ward's minimum variance method. The clusters were analyzed in terms of baseline characteristics; survival; and response to pulmonary arterial hypertension (PAH) therapy, expressed as changes from baseline to follow-up in functional class, 6-minute walking distance, cardiac biomarkers, and risk.
Three clusters were identified: Cluster 1 (n = 106; 12.6%): median age 45 years, 76% females, no comorbidities, mostly never smokers, DLCO ≥45%; Cluster 2 (n = 301; 35.8%): median age 75 years, 98% females, frequent comorbidities, no smoking history, DLCO mostly ≥45%; and Cluster 3 (n = 434; 51.6%): median age 72 years, 72% males, frequent comorbidities, history of smoking, and low DLCO. Patients in Cluster 1 had a better response to PAH treatment than patients in the 2 other clusters. Survival over 5 years was 84.6% in Cluster 1, 59.2% in Cluster 2, and 42.2% in Cluster 3 (unadjusted p < 0.001 for comparison between all groups).
The population of patients diagnosed with IPAH is heterogenous. This cluster analysis identified distinct phenotypes, which differed in clinical presentation, response to therapy, and survival.</description><identifier>ISSN: 1053-2498</identifier><identifier>EISSN: 1557-3117</identifier><identifier>DOI: 10.1016/j.healun.2020.09.011</identifier><identifier>PMID: 33082079</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>cluster ; mortality ; phenotypes ; pulmonary arterial hypertension ; survival</subject><ispartof>The Journal of heart and lung transplantation, 2020-12, Vol.39 (12), p.1435-1444</ispartof><rights>2020 The Authors</rights><rights>Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-434c121e5cbabae9061138eda8829869f2df07aef34f661551285c81f4bef9b03</citedby><cites>FETCH-LOGICAL-c474t-434c121e5cbabae9061138eda8829869f2df07aef34f661551285c81f4bef9b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1053249820317587$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33082079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoeper, Marius M.</creatorcontrib><creatorcontrib>Pausch, Christine</creatorcontrib><creatorcontrib>Grünig, Ekkehard</creatorcontrib><creatorcontrib>Klose, Hans</creatorcontrib><creatorcontrib>Staehler, Gerd</creatorcontrib><creatorcontrib>Huscher, Doerte</creatorcontrib><creatorcontrib>Pittrow, David</creatorcontrib><creatorcontrib>Olsson, Karen M.</creatorcontrib><creatorcontrib>Vizza, Carmine Dario</creatorcontrib><creatorcontrib>Gall, Henning</creatorcontrib><creatorcontrib>Benjamin, Nicola</creatorcontrib><creatorcontrib>Distler, Oliver</creatorcontrib><creatorcontrib>Opitz, Christian</creatorcontrib><creatorcontrib>Gibbs, J. Simon R.</creatorcontrib><creatorcontrib>Delcroix, Marion</creatorcontrib><creatorcontrib>Ghofrani, H. Ardeschir</creatorcontrib><creatorcontrib>Rosenkranz, Stephan</creatorcontrib><creatorcontrib>Ewert, Ralf</creatorcontrib><creatorcontrib>Kaemmerer, Harald</creatorcontrib><creatorcontrib>Lange, Tobias J.</creatorcontrib><creatorcontrib>Kabitz, Hans-Joachim</creatorcontrib><creatorcontrib>Skowasch, Dirk</creatorcontrib><creatorcontrib>Skride, Andris</creatorcontrib><creatorcontrib>Jureviciene, Elena</creatorcontrib><creatorcontrib>Paleviciute, Egle</creatorcontrib><creatorcontrib>Miliauskas, Skaidrius</creatorcontrib><creatorcontrib>Claussen, Martin</creatorcontrib><creatorcontrib>Behr, Juergen</creatorcontrib><creatorcontrib>Milger, Katrin</creatorcontrib><creatorcontrib>Halank, Michael</creatorcontrib><creatorcontrib>Wilkens, Heinrike</creatorcontrib><creatorcontrib>Wirtz, Hubert</creatorcontrib><creatorcontrib>Pfeuffer-Jovic, Elena</creatorcontrib><creatorcontrib>Harbaum, Lars</creatorcontrib><creatorcontrib>Scholtz, Werner</creatorcontrib><creatorcontrib>Dumitrescu, Daniel</creatorcontrib><creatorcontrib>Bruch, Leonhard</creatorcontrib><creatorcontrib>Coghlan, Gerry</creatorcontrib><creatorcontrib>Neurohr, Claus</creatorcontrib><creatorcontrib>Tsangaris, Iraklis</creatorcontrib><creatorcontrib>Gorenflo, Matthias</creatorcontrib><creatorcontrib>Scelsi, Laura</creatorcontrib><creatorcontrib>Vonk-Noordegraaf, Anton</creatorcontrib><creatorcontrib>Ulrich, Silvia</creatorcontrib><creatorcontrib>Held, Matthias</creatorcontrib><title>Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry</title><title>The Journal of heart and lung transplantation</title><addtitle>J Heart Lung Transplant</addtitle><description>The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients with pre-capillary pulmonary hypertension of unknown origin. There is considerable variability in the clinical presentation of these patients.
Using data from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension, we performed a cluster analysis of 841 patients with IPAH based on age, sex, diffusion capacity of the lung for carbon monoxide (DLCO; <45% vs ≥45% predicted), smoking status, and presence of comorbidities (obesity, hypertension, coronary heart disease, and diabetes mellitus). A hierarchical agglomerative clustering algorithm was performed using Ward's minimum variance method. The clusters were analyzed in terms of baseline characteristics; survival; and response to pulmonary arterial hypertension (PAH) therapy, expressed as changes from baseline to follow-up in functional class, 6-minute walking distance, cardiac biomarkers, and risk.
Three clusters were identified: Cluster 1 (n = 106; 12.6%): median age 45 years, 76% females, no comorbidities, mostly never smokers, DLCO ≥45%; Cluster 2 (n = 301; 35.8%): median age 75 years, 98% females, frequent comorbidities, no smoking history, DLCO mostly ≥45%; and Cluster 3 (n = 434; 51.6%): median age 72 years, 72% males, frequent comorbidities, history of smoking, and low DLCO. Patients in Cluster 1 had a better response to PAH treatment than patients in the 2 other clusters. Survival over 5 years was 84.6% in Cluster 1, 59.2% in Cluster 2, and 42.2% in Cluster 3 (unadjusted p < 0.001 for comparison between all groups).
The population of patients diagnosed with IPAH is heterogenous. This cluster analysis identified distinct phenotypes, which differed in clinical presentation, response to therapy, and survival.</description><subject>cluster</subject><subject>mortality</subject><subject>phenotypes</subject><subject>pulmonary arterial hypertension</subject><subject>survival</subject><issn>1053-2498</issn><issn>1557-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtO3TAQQK2qqFDgDxDyspukfuXhDRK6ghYJRFW1a8txxsRXiR3sBCl_j9GFLruah87MaA5CF5SUlND6-74cQI-rLxlhpCSyJJR-Qie0qpqCU9p8zjmpeMGEbI_R15T2hBDGK_YFHXNOWkYaeYL8Xe_CrJfBGTyv4xS8jhvWcYHo9IiHbYac--SCx_MAPiy5k3APGZichx53GzbjmnKNtdfjllzCNoYJLwPg3ePDr5vf1zjCk0tL3M7QkdVjgvP3eIr-3t782f0s7h9_3O2u7wsjGrEUggtDGYXKdLrTIElNKW-h123LZFtLy3pLGg2WC1vX-WXK2sq01IoOrOwIP0XfDnvnGJ5XSIuaXDIwjtpDWJNiomKyaSTnGRUH1MSQUgSr5uimbEFRot5Mq706mFZvphWRKpvOY5fvF9Zugv7f0IfaDFwdAMh_vjiIKhkH3kDvIphF9cH9_8Ir1M2TTg</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Hoeper, Marius M.</creator><creator>Pausch, Christine</creator><creator>Grünig, Ekkehard</creator><creator>Klose, Hans</creator><creator>Staehler, Gerd</creator><creator>Huscher, Doerte</creator><creator>Pittrow, David</creator><creator>Olsson, Karen M.</creator><creator>Vizza, Carmine Dario</creator><creator>Gall, Henning</creator><creator>Benjamin, Nicola</creator><creator>Distler, Oliver</creator><creator>Opitz, Christian</creator><creator>Gibbs, J. Simon R.</creator><creator>Delcroix, Marion</creator><creator>Ghofrani, H. Ardeschir</creator><creator>Rosenkranz, Stephan</creator><creator>Ewert, Ralf</creator><creator>Kaemmerer, Harald</creator><creator>Lange, Tobias J.</creator><creator>Kabitz, Hans-Joachim</creator><creator>Skowasch, Dirk</creator><creator>Skride, Andris</creator><creator>Jureviciene, Elena</creator><creator>Paleviciute, Egle</creator><creator>Miliauskas, Skaidrius</creator><creator>Claussen, Martin</creator><creator>Behr, Juergen</creator><creator>Milger, Katrin</creator><creator>Halank, Michael</creator><creator>Wilkens, Heinrike</creator><creator>Wirtz, Hubert</creator><creator>Pfeuffer-Jovic, Elena</creator><creator>Harbaum, Lars</creator><creator>Scholtz, Werner</creator><creator>Dumitrescu, Daniel</creator><creator>Bruch, Leonhard</creator><creator>Coghlan, Gerry</creator><creator>Neurohr, Claus</creator><creator>Tsangaris, Iraklis</creator><creator>Gorenflo, Matthias</creator><creator>Scelsi, Laura</creator><creator>Vonk-Noordegraaf, Anton</creator><creator>Ulrich, Silvia</creator><creator>Held, Matthias</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry</title><author>Hoeper, Marius M. ; Pausch, Christine ; Grünig, Ekkehard ; Klose, Hans ; Staehler, Gerd ; Huscher, Doerte ; Pittrow, David ; Olsson, Karen M. ; Vizza, Carmine Dario ; Gall, Henning ; Benjamin, Nicola ; Distler, Oliver ; Opitz, Christian ; Gibbs, J. Simon R. ; Delcroix, Marion ; Ghofrani, H. Ardeschir ; Rosenkranz, Stephan ; Ewert, Ralf ; Kaemmerer, Harald ; Lange, Tobias J. ; Kabitz, Hans-Joachim ; Skowasch, Dirk ; Skride, Andris ; Jureviciene, Elena ; Paleviciute, Egle ; Miliauskas, Skaidrius ; Claussen, Martin ; Behr, Juergen ; Milger, Katrin ; Halank, Michael ; Wilkens, Heinrike ; Wirtz, Hubert ; Pfeuffer-Jovic, Elena ; Harbaum, Lars ; Scholtz, Werner ; Dumitrescu, Daniel ; Bruch, Leonhard ; Coghlan, Gerry ; Neurohr, Claus ; Tsangaris, Iraklis ; Gorenflo, Matthias ; Scelsi, Laura ; Vonk-Noordegraaf, Anton ; Ulrich, Silvia ; Held, Matthias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-434c121e5cbabae9061138eda8829869f2df07aef34f661551285c81f4bef9b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>cluster</topic><topic>mortality</topic><topic>phenotypes</topic><topic>pulmonary arterial hypertension</topic><topic>survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoeper, Marius M.</creatorcontrib><creatorcontrib>Pausch, Christine</creatorcontrib><creatorcontrib>Grünig, Ekkehard</creatorcontrib><creatorcontrib>Klose, Hans</creatorcontrib><creatorcontrib>Staehler, Gerd</creatorcontrib><creatorcontrib>Huscher, Doerte</creatorcontrib><creatorcontrib>Pittrow, David</creatorcontrib><creatorcontrib>Olsson, Karen M.</creatorcontrib><creatorcontrib>Vizza, Carmine Dario</creatorcontrib><creatorcontrib>Gall, Henning</creatorcontrib><creatorcontrib>Benjamin, Nicola</creatorcontrib><creatorcontrib>Distler, Oliver</creatorcontrib><creatorcontrib>Opitz, Christian</creatorcontrib><creatorcontrib>Gibbs, J. Simon R.</creatorcontrib><creatorcontrib>Delcroix, Marion</creatorcontrib><creatorcontrib>Ghofrani, H. Ardeschir</creatorcontrib><creatorcontrib>Rosenkranz, Stephan</creatorcontrib><creatorcontrib>Ewert, Ralf</creatorcontrib><creatorcontrib>Kaemmerer, Harald</creatorcontrib><creatorcontrib>Lange, Tobias J.</creatorcontrib><creatorcontrib>Kabitz, Hans-Joachim</creatorcontrib><creatorcontrib>Skowasch, Dirk</creatorcontrib><creatorcontrib>Skride, Andris</creatorcontrib><creatorcontrib>Jureviciene, Elena</creatorcontrib><creatorcontrib>Paleviciute, Egle</creatorcontrib><creatorcontrib>Miliauskas, Skaidrius</creatorcontrib><creatorcontrib>Claussen, Martin</creatorcontrib><creatorcontrib>Behr, Juergen</creatorcontrib><creatorcontrib>Milger, Katrin</creatorcontrib><creatorcontrib>Halank, Michael</creatorcontrib><creatorcontrib>Wilkens, Heinrike</creatorcontrib><creatorcontrib>Wirtz, Hubert</creatorcontrib><creatorcontrib>Pfeuffer-Jovic, Elena</creatorcontrib><creatorcontrib>Harbaum, Lars</creatorcontrib><creatorcontrib>Scholtz, Werner</creatorcontrib><creatorcontrib>Dumitrescu, Daniel</creatorcontrib><creatorcontrib>Bruch, Leonhard</creatorcontrib><creatorcontrib>Coghlan, Gerry</creatorcontrib><creatorcontrib>Neurohr, Claus</creatorcontrib><creatorcontrib>Tsangaris, Iraklis</creatorcontrib><creatorcontrib>Gorenflo, Matthias</creatorcontrib><creatorcontrib>Scelsi, Laura</creatorcontrib><creatorcontrib>Vonk-Noordegraaf, Anton</creatorcontrib><creatorcontrib>Ulrich, Silvia</creatorcontrib><creatorcontrib>Held, Matthias</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of heart and lung transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoeper, Marius M.</au><au>Pausch, Christine</au><au>Grünig, Ekkehard</au><au>Klose, Hans</au><au>Staehler, Gerd</au><au>Huscher, Doerte</au><au>Pittrow, David</au><au>Olsson, Karen M.</au><au>Vizza, Carmine Dario</au><au>Gall, Henning</au><au>Benjamin, Nicola</au><au>Distler, Oliver</au><au>Opitz, Christian</au><au>Gibbs, J. Simon R.</au><au>Delcroix, Marion</au><au>Ghofrani, H. Ardeschir</au><au>Rosenkranz, Stephan</au><au>Ewert, Ralf</au><au>Kaemmerer, Harald</au><au>Lange, Tobias J.</au><au>Kabitz, Hans-Joachim</au><au>Skowasch, Dirk</au><au>Skride, Andris</au><au>Jureviciene, Elena</au><au>Paleviciute, Egle</au><au>Miliauskas, Skaidrius</au><au>Claussen, Martin</au><au>Behr, Juergen</au><au>Milger, Katrin</au><au>Halank, Michael</au><au>Wilkens, Heinrike</au><au>Wirtz, Hubert</au><au>Pfeuffer-Jovic, Elena</au><au>Harbaum, Lars</au><au>Scholtz, Werner</au><au>Dumitrescu, Daniel</au><au>Bruch, Leonhard</au><au>Coghlan, Gerry</au><au>Neurohr, Claus</au><au>Tsangaris, Iraklis</au><au>Gorenflo, Matthias</au><au>Scelsi, Laura</au><au>Vonk-Noordegraaf, Anton</au><au>Ulrich, Silvia</au><au>Held, Matthias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry</atitle><jtitle>The Journal of heart and lung transplantation</jtitle><addtitle>J Heart Lung Transplant</addtitle><date>2020-12</date><risdate>2020</risdate><volume>39</volume><issue>12</issue><spage>1435</spage><epage>1444</epage><pages>1435-1444</pages><issn>1053-2498</issn><eissn>1557-3117</eissn><abstract>The term idiopathic pulmonary arterial hypertension (IPAH) is used to categorize patients with pre-capillary pulmonary hypertension of unknown origin. There is considerable variability in the clinical presentation of these patients.
Using data from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension, we performed a cluster analysis of 841 patients with IPAH based on age, sex, diffusion capacity of the lung for carbon monoxide (DLCO; <45% vs ≥45% predicted), smoking status, and presence of comorbidities (obesity, hypertension, coronary heart disease, and diabetes mellitus). A hierarchical agglomerative clustering algorithm was performed using Ward's minimum variance method. The clusters were analyzed in terms of baseline characteristics; survival; and response to pulmonary arterial hypertension (PAH) therapy, expressed as changes from baseline to follow-up in functional class, 6-minute walking distance, cardiac biomarkers, and risk.
Three clusters were identified: Cluster 1 (n = 106; 12.6%): median age 45 years, 76% females, no comorbidities, mostly never smokers, DLCO ≥45%; Cluster 2 (n = 301; 35.8%): median age 75 years, 98% females, frequent comorbidities, no smoking history, DLCO mostly ≥45%; and Cluster 3 (n = 434; 51.6%): median age 72 years, 72% males, frequent comorbidities, history of smoking, and low DLCO. Patients in Cluster 1 had a better response to PAH treatment than patients in the 2 other clusters. Survival over 5 years was 84.6% in Cluster 1, 59.2% in Cluster 2, and 42.2% in Cluster 3 (unadjusted p < 0.001 for comparison between all groups).
The population of patients diagnosed with IPAH is heterogenous. This cluster analysis identified distinct phenotypes, which differed in clinical presentation, response to therapy, and survival.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33082079</pmid><doi>10.1016/j.healun.2020.09.011</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1053-2498 |
ispartof | The Journal of heart and lung transplantation, 2020-12, Vol.39 (12), p.1435-1444 |
issn | 1053-2498 1557-3117 |
language | eng |
recordid | cdi_proquest_miscellaneous_2452977933 |
source | Elsevier ScienceDirect Journals |
subjects | cluster mortality phenotypes pulmonary arterial hypertension survival |
title | Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A31%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Idiopathic%20pulmonary%20arterial%20hypertension%20phenotypes%20determined%20by%20cluster%20analysis%20from%20the%20COMPERA%20registry&rft.jtitle=The%20Journal%20of%20heart%20and%20lung%20transplantation&rft.au=Hoeper,%20Marius%20M.&rft.date=2020-12&rft.volume=39&rft.issue=12&rft.spage=1435&rft.epage=1444&rft.pages=1435-1444&rft.issn=1053-2498&rft.eissn=1557-3117&rft_id=info:doi/10.1016/j.healun.2020.09.011&rft_dat=%3Cproquest_cross%3E2452977933%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2452977933&rft_id=info:pmid/33082079&rft_els_id=S1053249820317587&rfr_iscdi=true |